Noticias de ABT
Noticias del mercado
Últimas noticias sobre ABT — 804 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
La atención médica y la gestión de residuos ofrecen oportunidades de demanda a largo plazo más allá de la IA en 2027, con Abbott Laboratories, Johnson & Johnson, Stryker, Waste Management y Republic Services en el centro de atención.
El fondo de 3.400 millones de dólares vendió 340,3 millones de dólares en acciones, recortando las 48 posiciones y sin añadir ninguna.
Results are due October 21, 2026 before the market opens. Abbott Laboratories stock costs EUR 93.34
Abbott Laboratories (NYSE:ABT) is scheduled to report its earnings on Wednesday, October 21, 2026. The company has a market value of about $181.1 billion. Over the last twelve months it generated $46.6 billion in revenue and $7.3 billion in operating profit, with net income of $5.4 billion.
Abbott Laboratories (NYSE:ABT) received CE Mark for its Cologuard Plus colorectal cancer test under the EU In Vitro Diagnostic Regulation. The approval clears Abbott to offer the noninvasive stool based screening test in select European markets for colorectal cancer detection. The Cologuard Plus authorization expands Abbott
Abbott Laboratories has convinced a Michigan federal judge that a former employee's sex discrimination and retaliation lawsuit belongs in Illinois.
Abbott Laboratories has convinced a Michigan federal judge that a former employee's sex discrimination and retaliation lawsuit belongs in Illinois.
Abbott develops healthcare technologies and offers products including the Lingo glucose system. At L
Find the latest Abbott Laboratories (ABT) stock quote, history, news and other vital information to help you with your stock trading and investing.
Las acciones de Abbott Laboratories estaban a 92,59 EUR en las operaciones del fin de semana del 18 de octubre de 2026. Abbott enumeró dos
Form 4 Abbott Laboratories: Kevin T. Conroy (Director) For: 30 September
Página 7 de 41